They included stable (no response / no change) results in their count of "positive" results. There is no info on tumors that actually shrank in these results. A "stable" tumor is not good. All they tell you is "Six of 8 (75%) evaluable melanoma patients had stable disease or better".They also said "Four of the 8 patients continue to receive TH-302 after receiving TH-302 for 2.6 to 6.2 months"Stable tumor IS NOT GOOD. Why only 8 patients in trial? Why not share the rate of improvement if there is any?Why did 4 of the 8 trial patients stop treatment? Does not sound good at all. I'm watching this one for a pump and dump. Insiders bought stock and then publish this ridiculous nonsense that really gives you no real information? Very interesting.